Research-Grade Aromatase Inhibitor
Ultima Aromasin 25mg represents exemestane in pharmaceutical tablet form, manufactured by Ultima Pharmaceuticals for rigorous laboratory investigations. Exemestane is a steroidal aromatase inhibitor that functions as an irreversible enzyme inactivator, providing researchers with a powerful tool for studying estrogen biosynthesis pathways. This compound operates through covalent binding to the aromatase enzyme (CYP19A1), resulting in permanent inactivation that distinguishes it from competitive inhibitors in experimental protocols.
Research facilities investigating hormonal regulation mechanisms will find this formulation particularly valuable for studies examining estrogen suppression dynamics. The irreversible nature of exemestane’s aromatase binding creates unique research opportunities not available with reversible inhibitors, making it an essential reference compound for comparative studies. Laboratories focused on endocrine system research can examine how permanent enzyme inactivation affects downstream hormonal cascades in controlled experimental environments.
Laboratory Applications
Scientific teams studying breast cancer cell lines frequently utilise exemestane to investigate estrogen-dependent growth mechanisms and cellular response pathways. Researchers examining post-menopausal hormone profiles can analyse how complete aromatase inhibition affects tissue-specific estrogen production in experimental models. The compound’s pharmaceutical-grade formulation ensures consistent results across repeated experimental protocols, supporting reproducible research outcomes.
Advanced research programmes exploring hormonal interactions benefit from exemestane’s unique pharmacokinetic profile, which differs significantly from non-steroidal alternatives. Studies investigating bone metabolism, lipid profiles, and cardiovascular markers in estrogen-depleted environments rely on this compound’s predictable inhibition patterns. Comparative research projects examining different aromatase inhibitor classes require exemestane as a steroidal reference standard to establish baseline inhibition characteristics.
Product Specifications
| Active Compound | Exemestane |
|---|---|
| Concentration | 25mg per tablet |
| Manufacturer | Ultima Pharmaceuticals |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.40 g/mol |
| Storage Requirements | Room temperature, dry environment |
This pharmaceutical-grade preparation maintains stability under standard laboratory storage conditions, ensuring reliable performance throughout extended research programmes. The tablet formulation provides precise dosing capabilities essential for quantitative experimental designs requiring exact compound delivery.
Research Compliance Notice
Ultima Aromasin 25mg is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, clinical use, or therapeutic purposes. Researchers must ensure proper laboratory safety protocols and regulatory compliance when handling this compound. This product should only be used by qualified research professionals in controlled laboratory environments for legitimate scientific investigations. For comprehensive product specifications and research support, visit Stroid UK Shop, explore our aromatase inhibitor collection, or discover additional research compounds in our SARM category and peptide selection.
